SALADINI FRANCESCO

Francesco
Saladini
Ricercatore Legge 240/10 - tempo determinato

Teaching activities

Completion accademic year: 2021/2022

Course year: 1 First cycle degree (DM 270) DIETISTIC A.Y. 2021/2022
Course year: 1 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2021/2022

Completion accademic year: 2020/2021

Course year: 1 First cycle degree (DM 270) DIETISTIC A.Y. 2020/2021
Course year: 1 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2020/2021

Completion accademic year: 2019/2020

Course year: 1 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2019/2020

Research

Ultime pubblicazioni:

  • BRAI, A., Riva, V., SALADINI, F., ZAMPERINI, C., TRIVISANI, C.I., Garbelli, A., et al. (In corso di stampa). DDX3X inhibitors, an effective way to overcome HIV-1 resistance. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. - view more
  • Vicenti, I., Dragoni, F., Monti, M., Trombetta, C.M., Giannini, A., Boccuto, A., et al. (2021). Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells. JOURNAL OF GENERAL VIROLOGY, 102(1) [10.1099/jgv.0.001499]. - view more
  • Boccuto, A., Dragoni, F., Bergna, A., Ventura, C.D., Giammarino, F., Saladini, F., et al. (2021). Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals. JOURNAL OF INFECTION [10.1016/j.jinf.2021.08.005]. - view more
  • Vicenti, I., Zazzi, M., & Saladini, F. (2021). SARS-CoV-2 RNA dependent RNA polymerase as a therapeutic target for COVID-19. EXPERT OPINION ON THERAPEUTIC PATENTS, 31(4), 325-337 [10.1080/13543776.2021.1880568]. - view more
  • Saladini, F., Giammarino, F., Hosseini, B.A., Giannini, A., Boccuto, A., Dragoni, F., et al. (2021). In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 76(1), 130-134. - view more